Red White & Bloom Brands Q3 2020 Quarterly Report
01 Dezember 2020 - 12:30PM
Red White & Bloom Brands Inc. (CSE: RWB and OTCQX: RWBYF)
(“
RWB” or the “
Company”) is
pleased to announce that its interim consolidated financial
statements and related Management’s Discussion and Analysis for the
3rd quarter ended September 30, 2020 are available on
www.sedar.com. The Company is pleased to provide a summary of the
following highlights for Q3:
Select financial
results:
- Revenues for the
period totaled - $6.09 million CDN; revenues include Platinum Vape
results for 17 days in this quarter and exclude any results from
PharmaCo
- Gross margin
before fair value impacts was 69%
- Q3 2020 Adjusted
EBITDA was negative $5.66M and negative $2.89 for the nine months
ended September 30.
- Gain on fair
value of biological assets recognized during the quarter was $1.8M
and $10.1M for the five months ended September 30.
Operational highlights and recent
events
- Closed a $25m bought deal financing during Q3
- Closed on the acquisition of Platinum Vape during Q3
- Entered into agreements to expand Platinum Vape product
availability to the state of Arizona
- Began first harvest of Goliath Hemp in Illinois and commenced
shipping post end of Q3
- Shareholders approved deferring the conversion date of the
Preferred Shares to May 24, 2021
Chairman & CEO Brad Rogers
stated, “We are pleased with our pro forma revenue so far
this year and results for Q3, which included just a few days of
recognizing revenue from our Platinum operations along with
operations from our Granville Illinois operations. We are
continuing to move forward with our plans to close on our other
pending acquisition in Michigan, and have now set our sights on
additional THC opportunities elsewhere in the US while fortifying
our current operations.”
|
Q3 2020 |
Q3 YTD 2020 |
Net loss and comprehensive loss |
(8,367,015 |
) |
(30,576,480 |
) |
Add back |
|
|
Interest expense |
2,175,426 |
|
6,218,003 |
|
Depreciation and amortization |
1,911,238 |
|
3,233,484 |
|
Foreign exchange loss (gain) |
- |
|
(4,380,521 |
) |
Interest income |
(1,024,881 |
) |
(3,369,364 |
) |
Accretion expense |
290,000 |
|
(1,150,946 |
) |
Loss on revaluation of call option |
- |
|
1,420,001 |
|
Gain on Disposal |
(35,289 |
) |
(185,236 |
) |
Write off of deposit |
- |
|
1,853,059 |
|
Revaluation of investment |
(118,322 |
) |
(209,465 |
) |
Income Tax |
608,598 |
|
608,598 |
|
Listing Expense |
- |
|
22,832,281 |
|
Translation adjustment on consolidation of foreign
subsidiaries |
(1,104,375 |
) |
818,550 |
|
|
(5,664,620 |
) |
(2,888,036 |
) |
Adjusted EBITDA
About Red White & Bloom Brands
Inc.
The Company is positioning itself to be one of
the top three multi-state cannabis operators active in the U.S.
legal cannabis and hemp sector. RWB is predominately focusing its
investments on the major US markets, including Michigan, Illinois,
Massachusetts and California with respect to cannabis, and the US
and internationally for hemp-based CBD products.
Non-IFRS Financial Measures
Operational gross profit, EBITDA and Adjusted
EBITDA are non-IFRS measures and do not have standardized
definitions under IFRS. The Company has provided the non-IFRS
financial measures, which are not calculated or presented in
accordance with IFRS, as supplemental information and in addition
to the financial measures that are calculated and presented in
accordance with IFRS. These supplemental non-IFRS financial
measures are presented because management has evaluated the
financial results both including and excluding the adjusted items
and believe that the supplemental non-IFRS financial measures
presented provide additional perspective and insights when
analyzing the core operating performance of the business. These
supplemental non-IFRS financial measures should not be considered
superior to, as a substitute for or as an alternative to, and
should only be considered in conjunction with, the IFRS financial
measures presented herein. Accordingly, the following information
provides reconciliations of the supplemental non-IFRS financial
measures, presented herein to the most directly comparable
financial measures calculated and presented in accordance with
IFRS. *pro forma revenue is unaudited and assumes the company would
be licensed in each jurisdiction where the revenue is derived.
For more information about Red White & Bloom
Brands Inc., please contact:
Tyler Troup, Managing
DirectorCircadian Group IRIR@RedWhiteBloom.com
Visit us on the web:
www.RedWhiteBloom.com
Follow us on social
media:Twitter: @rwbbrandsFacebook:
@redwhitebloombrandsInstagram: @redwhitebloombrands
Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking
statements and information that are based on the beliefs of
management and reflect the Company’s current expectations. When
used in this press release, the words “estimate”, “project”,
“belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”,
“may” or “should” and the negative of these words or such
variations thereon or comparable terminology are intended to
identify forward-looking statements and information. The
forward-looking statements and information in this press release
includes information relating to the implementation of the
Company’s business plan including the completion of the Platinum
Vape acquisition, the PharmaCo acquisition and the bought deal
financing. Such statements and information reflect the current view
of the Company with respect to risks and uncertainties that may
cause actual results to differ materially from those contemplated
in those forward-looking statements and information.
By their nature, forward-looking statements
involve known and unknown risks, uncertainties and other factors
which may cause our actual results, performance or achievements, or
other future events, to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among others, the
following risks: risks associated with the implementation of the
Company’s business plan and matters relating thereto, risks
associated with the cannabis industry, competition, regulatory
change, the need for additional financing, reliance on key
personnel, the potential for conflicts of interest among certain
officers or directors, and the volatility of the Company’s common
share price and volume. Forward-looking statements are made based
on management’s beliefs, estimates and opinions on the date that
statements are made, and the Company undertakes no obligation to
update forward-looking statements if these beliefs, estimates and
opinions or other circumstances should change. Investors are
cautioned against attributing undue certainty to forward-looking
statements.
There are a number of important factors that
could cause the Company’s actual results to differ materially from
those indicated or implied by forward-looking statements and
information. Such factors include, among others, risks related to
the Company’s proposed business, such as failure of the business
strategy and government regulation; risks related to the Company’s
operations, such as additional financing requirements and access to
capital, reliance on key and qualified personnel, insurance,
competition, intellectual property and reliable supply chains;
risks related to the Company and its business generally. The
Company cautions that the foregoing list of material factors is not
exhaustive. When relying on the Company’s forward-looking
statements and information to make decisions, investors and others
should carefully consider the foregoing factors and other
uncertainties and potential events. The Company has assumed a
certain progression, which may not be realized. It has also assumed
that the material factors referred to in the previous paragraph
will not cause such forward-looking statements and information to
differ materially from actual results or events. However, the list
of these factors is not exhaustive and is subject to change and
there can be no assurance that such assumptions will reflect the
actual outcome of such items or factors. While the Company may
elect to, it does not undertake to update this information at any
particular time.
THE FORWARD-LOOKING INFORMATION CONTAINED IN
THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF
THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO
CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE
ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS
INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO,
IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR
TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
Red White & Bloom Brands (CSE:RWB)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Red White & Bloom Brands (CSE:RWB)
Historical Stock Chart
Von Dez 2023 bis Dez 2024